Adrenaline Tartrate Injection 1 ml (Rathi Lab) belongs to a class of medicines called 'sympathomimetic', primarily used for the treatment of cardiac arrest, hypotension due to septic shock and life-threatening allergic reactions. Cardiac arrest is a sudden loss of blood flow resulting from the failure of the heart to pump effectively. Severe allergic reactions, including anaphylaxis due to foods, drugs, insect stings, bites, or other allergens. It may cause symptoms like breathing difficulty, facial swelling, dizziness, confusion and hives.

Adrenaline Tartrate Injection 1 ml (Rathi Lab) contains 'adrenaline', also called epinephrine. Adrenaline Tartrate Injection 1 ml (Rathi Lab) is used to increase blood flow to the heart and increase the chance of restoring a heartbeat in cardiac arrest. Adrenaline Tartrate Injection 1 ml (Rathi Lab) increases mean arterial blood pressure in adult patients with hypotension associated with septic shock. It is also used to increase blood flow through veins by constricting blood vessels and helps to relax the muscles, which block the airways and allow breathing to return to normal in allergic reactions due to foods, drugs, insect stings or bites or any other allergens.

Adrenaline Tartrate Injection 1 ml (Rathi Lab) is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Adrenaline Tartrate Injection 1 ml (Rathi Lab) may cause common side effects like increased heart rate, difficulty breathing, blurred vision, headache, dizziness, mood or mental changes, and an increase in blood pressure. If these side effects persist, consult your doctor immediately.

Adrenaline Tartrate Injection 1 ml (Rathi Lab) should not be taken if you are allergic to it. Inform your doctor if you are using any medicines other than Adrenaline Tartrate Injection 1 ml (Rathi Lab). Inform your doctor if you are a pregnant/breastfeeding woman. Do not use Adrenaline Tartrate Injection 1 ml (Rathi Lab) if the solution is discoloured. Adrenaline Tartrate Injection 1 ml (Rathi Lab) should be used with caution in brain disorders, pheochromocytoma (tumour on adrenal gland), pulmonary oedema, kidney impairment, liver impairment, hypertension, hyperthyroidism, diabetes mellitus, and narrow-angle glaucoma.

Adrenaline Tartrate Injection 1 ml (Rathi Lab) contains 'adrenaline'; it is also called epinephrine. It belongs to a class of medicines called 'sympathomimetic', primarily taken for the treatment of cardiac arrest, hypotension due to septic shock and life-threatening allergic reactions. Adrenaline Tartrate Injection 1 ml (Rathi Lab) works by increasing blood flow to the heart and also increases the chance of restoring a heartbeat in cardiac arrest. Adrenaline Tartrate Injection 1 ml (Rathi Lab) increases mean arterial blood pressure in adult patients with hypotension associated with septic shock. It is also used to increase blood flow through veins by constricting blood vessels and helps to relax the muscles, which block the airways and allow breathing to return to normal in allergic reactions due to foods, drugs, insect stings or bites or any other allergens. Adrenaline Tartrate Injection 1 ml (Rathi Lab) is also used in the treatment of bradycardia(slow heart rate), mydriasis( dilation of the pupil of the eye) and acute asthma.

Adrenaline Tartrate Injection 1 ml (Rathi Lab) should not be taken if you are allergic to it. Inform your doctor if you are using any medicines other than Adrenaline Tartrate Injection 1 ml (Rathi Lab). Inform your doctor if you are a pregnant/breastfeeding woman. Adrenaline Tartrate Injection 1 ml (Rathi Lab) should be used with caution in brain disorders, pheochromocytoma (tumour on adrenal gland), pulmonary oedema, kidney impairment, hypertension, and liver impairment. Adrenaline Tartrate Injection 1 ml (Rathi Lab) is not recommended for diabetes, Parkinson's disease, hyperthyroidism, narrow-angle glaucoma and cardiovascular diseases. Adrenaline Tartrate Injection 1 ml (Rathi Lab) is for emergency use only, and medical supervision of the patients is necessary after administration.